DHR
Price
$229.47
Change
-$2.01 (-0.87%)
Updated
Dec 26, 02:52 PM (EDT)
Capitalization
163.5B
33 days until earnings call
Intraday BUY SELL Signals
DSRLF
Price
$76.08
Change
+$1.74 (+2.34%)
Updated
Dec 24 closing price
Capitalization
4.16B
Intraday BUY SELL Signals
Interact to see
Advertisement

DHR vs DSRLF

Header iconDHR vs DSRLF Comparison
Open Charts DHR vs DSRLFBanner chart's image
Danaher
Price$229.47
Change-$2.01 (-0.87%)
Volume$400
Capitalization163.5B
Diasorin S.R.L
Price$76.08
Change+$1.74 (+2.34%)
Volume$205
Capitalization4.16B
DHR vs DSRLF Comparison Chart in %
DHR
Daily Signal:
Gain/Loss:
DSRLF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DHR vs. DSRLF commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Buy and DSRLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (DHR: $231.47 vs. DSRLF: $76.08)
Brand notoriety: DHR and DSRLF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 21% vs. DSRLF: 152%
Market capitalization -- DHR: $163.5B vs. DSRLF: $4.16B
DHR [@Medical Specialties] is valued at $163.5B. DSRLF’s [@Medical Specialties] market capitalization is $4.16B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 1 FA rating(s) are green whileDSRLF’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 1 green, 4 red.
  • DSRLF’s FA Score: 1 green, 4 red.
According to our system of comparison, DHR is a better buy in the long-term than DSRLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 3 TA indicator(s) are bullish while DSRLF’s TA Score has 3 bullish TA indicator(s).

  • DHR’s TA Score: 3 bullish, 5 bearish.
  • DSRLF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, DSRLF is a better buy in the short-term than DHR.

Price Growth

DHR (@Medical Specialties) experienced а +3.97% price change this week, while DSRLF (@Medical Specialties) price change was +2.34% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.56%. For the same industry, the average monthly price growth was -2.21%, and the average quarterly price growth was +21.69%.

Reported Earning Dates

DHR is expected to report earnings on Jan 28, 2026.

Industries' Descriptions

@Medical Specialties (+1.56% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($163B) has a higher market cap than DSRLF($4.16B). DHR has higher P/E ratio than DSRLF: DHR (47.63) vs DSRLF (18.61). DHR YTD gains are higher at: 1.330 vs. DSRLF (-28.800). DHR has higher annual earnings (EBITDA): 6.87B vs. DSRLF (406M). DHR has more cash in the bank: 1.53B vs. DSRLF (174M). DSRLF has less debt than DHR: DSRLF (769M) vs DHR (16.9B). DHR has higher revenues than DSRLF: DHR (24.3B) vs DSRLF (1.22B).
DHRDSRLFDHR / DSRLF
Capitalization163B4.16B3,915%
EBITDA6.87B406M1,691%
Gain YTD1.330-28.800-5%
P/E Ratio47.6318.61256%
Revenue24.3B1.22B2,000%
Total Cash1.53B174M878%
Total Debt16.9B769M2,198%
FUNDAMENTALS RATINGS
DHR vs DSRLF: Fundamental Ratings
DHR
DSRLF
OUTLOOK RATING
1..100
850
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
6
Undervalued
PROFIT vs RISK RATING
1..100
73100
SMR RATING
1..100
8063
PRICE GROWTH RATING
1..100
2863
P/E GROWTH RATING
1..100
3789
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DSRLF's Valuation (6) in the null industry is somewhat better than the same rating for DHR (51) in the Medical Specialties industry. This means that DSRLF’s stock grew somewhat faster than DHR’s over the last 12 months.

DHR's Profit vs Risk Rating (73) in the Medical Specialties industry is in the same range as DSRLF (100) in the null industry. This means that DHR’s stock grew similarly to DSRLF’s over the last 12 months.

DSRLF's SMR Rating (63) in the null industry is in the same range as DHR (80) in the Medical Specialties industry. This means that DSRLF’s stock grew similarly to DHR’s over the last 12 months.

DHR's Price Growth Rating (28) in the Medical Specialties industry is somewhat better than the same rating for DSRLF (63) in the null industry. This means that DHR’s stock grew somewhat faster than DSRLF’s over the last 12 months.

DHR's P/E Growth Rating (37) in the Medical Specialties industry is somewhat better than the same rating for DSRLF (89) in the null industry. This means that DHR’s stock grew somewhat faster than DSRLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRDSRLF
RSI
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
45%
Momentum
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
45%
MACD
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
30%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
27%
Advances
ODDS (%)
Bullish Trend 3 days ago
55%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
60%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
31%
Aroon
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
25%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signal:
Gain/Loss:
DSRLF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFEBX50.600.20
+0.40%
MFS Value B
HLHIX31.200.10
+0.32%
Virtus KAR Health Sciences Inst
TRBIX26.670.08
+0.30%
Nuveen Small Cap Blend Idx Retire
BSMKX18.710.04
+0.21%
iShares Russell Small/Mid-Cap Idx K
INFCX13.74-0.03
-0.22%
Kotak India Equity Fund Class C

DHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, DHR has been closely correlated with TMO. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if DHR jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DHR
1D Price
Change %
DHR100%
+0.28%
TMO - DHR
79%
Closely correlated
-0.14%
A - DHR
76%
Closely correlated
-0.03%
RVTY - DHR
71%
Closely correlated
-0.82%
IQV - DHR
70%
Closely correlated
+0.39%
MTD - DHR
69%
Closely correlated
+0.18%
More

DSRLF and

Correlation & Price change

A.I.dvisor tells us that DSRLF and PRE have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DSRLF and PRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSRLF
1D Price
Change %
DSRLF100%
+2.34%
PRE - DSRLF
26%
Poorly correlated
-1.17%
BJDX - DSRLF
22%
Poorly correlated
-5.27%
DGX - DSRLF
20%
Poorly correlated
+0.48%
DHR - DSRLF
20%
Poorly correlated
+0.28%
ESLOF - DSRLF
10%
Poorly correlated
+1.53%
More